Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease

NCT00351286 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Arterial Disease
Intermittent Claudication

Interventions

DRUG: L-citrulline tablets, 1000 mg
DRUG: Placebo tablets matching L-citrulline tablets
DRUG: Background simvastatin at a stable dose of 40 mg qHS

Sponsor

Angiogenix